Unlocking Opportunities in the Tumor Models Market: 2025-2034 Forecast Report

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Tumor Models Industry Market Size Be by 2025?
In recent years, there has been a swift expansion in the size of the tumor model market. It is predicted to increase from $1.92 billion in 2024 to $2.13 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.3%. The previous growth can be ascribed to a surge in cancer cases, escalating demand for customized medicine, a rising need for improved preclinical predictability, and an increase in the use of patient-derived xenograft models, along with a growing dependence on in vivo efficacy data.

What's the Long-Term Growth Forecast for the Tumor Models Market Size Through 2029?
In the coming years, the size of the tumor model market is projected to experience swift growth. The market is anticipated to expand to a valuation of $3.23 billion in 2029, marking a compound annual growth rate (CAGR) of 10.9%. This expansion in the forecast period can be credited to various factors such as the rise in focus on models that resonate with human relevance, heightened demand in precision oncology and immuno-oncology, an upswing in demand for high-throughput screening models, growing interest in unique cancer models. Foreseen trends during this period encompass the progression of three-dimensional (3D) cell culture models, enhancements in cell culture technology, heightened involvement of AI in cancer modelling, pharmaceutical research and developments, and the advent of patient-derived organoids.

View the full report here:
https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report

What Are the Key Growth Drivers Fueling the Tumor Models Market Expansion?
The surge in preference for customized healthcare solutions is anticipated to fuel the expansion of the tumor models market. Customized or personalized medicine is a healthcare model that leverages an individual's genetic makeup and lifestyle habits to create more tailored treatment strategies. The increasing interest in this type of healthcare is primarily because it offers real-time monitoring and treatments that cater specifically to a person's unique biological makeup. Tumor models play a crucial part in this field by providing a platform where researchers and medicos can test and predict how a patient's tumor may react to specific medical courses. These models emulate the characteristics of authentic human cancers, thus facilitating a more personalized therapeutic approach. To illustrate, in February 2023, the Personalized Medicine Coalition, an American professional membership organization, revealed that 12 new personalized medicines approved in 2022 constituted about 34% of all newly green-lighted therapies. This marked a significant rise from prior years. Consequently, the rising inclination towards personalized medicine is bolstering the progression of the tumor models market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp

What Are the Key Trends Driving Tumor Models Market Growth?
Major firms active in the tumor models market are turning their attention to the creation of cutting-edge solutions, such as tumor spheroid models with the aim of improving the physiological significance and predictive precision of in vitro cancer models. Tumor spheroid models are three-dimensional (3D) cancer cell aggregates that naturally form spherical organizations in culture. As an example, Predictive Oncology, an advanced 3D cell culture technology and oncology solution enterprise based in the US, introduced its groundbreaking 3D cell technology in June 2024 to speed up the discovery of cancer treatment drugs. This technology boasts novel features like state-of-the-art 3D tumor spheroid and organoid models that accurately replicate the tumor microenvironment. It also offers high-throughput screening capabilities for swift drug testing, support for personalized tumor models derived from patients, comprehensive analysis of drug penetration in 3D structures, and the liaison with AI-infused data analytics to provide improved predictive precision and more profound insights into therapeutic responses.

How Is the Tumor Models Market Segmented?
The tumor models market covered in this report is segmented

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models
2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies
3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:
1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models
2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models
3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models
4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27441&type=smp

Which Companies Are Leading the Charge in Tumor Models Market Innovation?
Major companies operating in the tumor models market are Merck & Co Inc., LabCorp Holdings Inc., Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., Reaction Biology Corporation, InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH, and Hera BioLabs Inc.

Which Regions Are Leading the Global Tumor Models Market in Revenue?
North America was the largest region in the tumor models market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27441

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.